Anika Therapeutics, Inc. (ANIK) free cash flow

Free cash flow · fiscal 2025
$4.36M

Anika Therapeutics, Inc. (ANIK) generated free cash flow of $4.36M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$2.93M. Figures as of 18 Nov 2026, 12:42 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$4.36M
Growth, 5 years
−17.5% a year
Growth, 10 years
−17.7% a year
Highest on record
$38.43Mfiscal 2014
Lowest on record
-$7.22Mfiscal 2023
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Anika Therapeutics, Inc. free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow shrank at a compound 17.5% a year; over ten years the rate was −17.7% a year. Across the 17 fiscal years on record (2009–2025), the highest was $38.43M in fiscal 2014 and the lowest -$7.22M in fiscal 2023.

History · 17 fiscal years

Free cash flow by fiscal year

Anika Therapeutics, Inc. free cash flow, year by year

Anika Therapeutics, Inc. (ANIK) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$4.36M—
2024-$2.93M—
2023-$7.22M—
2022-$3.08M 194.6% down
2021$3.25M 71.5% down
2020$11.44M 66.5% down
2019$34.18M 12.9% up
2018$30.26M 4.9% down
2017$31.83M 205.1% up
2016$10.43M 66.0% down
2015$30.69M 20.1% down
2014$38.43M 55.4% up
2013$24.72M 173.4% up
2012$9.04M 3.1% up
2011$8.77M 73.1% up
2010$5.07M—
2009-$867.53K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on ANIK

Anika Therapeutics, Inc., figure by figure

Anika Therapeutics, Inc. (ANIK) overview: price, valuation and scorecard

Anika Therapeutics, Inc. free cash flow: questions and answers

What is Anika Therapeutics, Inc.'s free cash flow?

Anika Therapeutics, Inc. (ANIK) generated free cash flow of $4.36M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$2.93M.

What is the growth rate of Anika Therapeutics, Inc.'s free cash flow?

Over the five fiscal years to 2025 free cash flow shrank at a compound 17.5% a year; over ten years the rate was −17.7% a year.

What are the highest and lowest free cash flow figures on record for Anika Therapeutics, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $38.43M in fiscal 2014 and the lowest -$7.22M in fiscal 2023.

How is Anika Therapeutics, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Anika Therapeutics, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Anika Therapeutics, Inc. (ANIK) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/ANIK/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.